pillbase.ru

Avonex

Active substance: interferon beta-1a

INJECTION, SOLUTION · INTERFERON BETA-1A 30 ug/.5mL

United StatesActive

Marketing holder: Biogen Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 11
  • Генфаксон®
    раствор для подкожного введения, 6 млн МЕ (22 мкг), 0.5 мл (original in Russian, GRLS)
    ЛП-№(016106)-(РГ-RU)
    Тютор С.А.С.И.Ф.И.А.
  • Генфаксон®
    раствор для подкожного введения, 6 млн.МЕ, 0.5 мл (original in Russian, GRLS)
    ЛСР-003037/10
    Лаборатория Тютор С.А.С.И.Ф.И.А.
  • Интерферон бета-1а
    субстанция-раствор, ~, 0-280 мл (original in Russian, GRLS)
    ФС-001965
    ООО "Мерк"
  • Ребиф®
    раствор для подкожного введения, 22 мкг/0.5 мл, 0.5 мл (original in Russian, GRLS)
    ЛП-№(006073)-(РГ-RU)
    ООО "Мерк"
  • Ребиф®
    раствор для подкожного введения, 22 мкг/0.5 мл, 0.5 мл (original in Russian, GRLS)
    П N014563/01
    ООО "Мерк"
All products in this country (11)
EU 3
  • Avonex
    interferon beta-1a
    EMEA/H/C/000102
    Biogen Netherlands B.V. 
  • Biferonex
    interferon beta-1a
    EMEA/H/C/000901
    BioPartners GmbH
  • Rebif
    interferon beta-1a
    EMEA/H/C/000136
    Merck Europe B.V. 
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-2fc2-76e9-97a8-995f2fe92b41,01a120c3-75e9-7d33-97bb-19951617d52a,01a120c3-78ae-794b-824e-2547346141e1,01a120c3-eed5-7ea8-ba07-ac4b369404b3,01a120c3-f86b-7876-bcb8-91248cc015fd;count=10 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-5f33-7a1e-922a-8eb0d2d9bc83,01a1208c-80dc-7036-a3ce-921ba6eda1b3,01a1208d-51ab-7e67-861f-828bd835a7ea,01a1208e-486c-703c-852b-352ea8e51fa4,01a12091-9960-7023-a37d-bd1e55385644;count=10 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
59627-002
Registration status
Active
Dispensing
Prescription only
Route
INTRAMUSCULAR
Sources
  • product · openFDA NDC · 59627-002 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 59627-002 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 59627-002 · Verified 2026-10-09 · open in source